EDGAR Filing Documents for 0001193125-07-247001

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-07-247001

Filing Date

2007-11-14

Accepted

2007-11-14 13:53:25

Documents

Period of Report

2007-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	d10q.htm	10-Q	433744
2	FORM OF INDEMNIFICATION AGREEMENT	dex107.htm	EX-10.7	41247
3	CERTIFICATION PURSUANT TO RULE 13A-14(A) - JOSEPH K. BELANOFF, M.D.	dex311.htm	EX-31.1	8565
4	CERTIFICATION PURSUANT TO RULE 13A-14(A) - ANNE M. LEDOUX	dex312.htm	EX-31.2	8485
5	CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 OF JOSEPH K. BELANOFF, M.D.	dex321.htm	EX-32.1	3623
6	CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 OF ANNE M. LEDOUX	dex322.htm	EX-32.2	3546
	Complete submission text file	0001193125-07-247001.txt		500459

Mailing Address

Business Address 275 MIDDLEFIELD ROAD SUITE A MENLO PARK CA 94025

CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50679 | Film No.: 071243076
SIC: 2834 Pharmaceutical Preparations